| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272275.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028754992 |
Resistant |
| ENSG00000272275.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022208857 |
Resistant |
| ENSG00000272275.1 |
Ponatinib |
Breast invasive carcinoma |
0.043752929 |
Sensitive |
